BST1 and neoplasm: We previously showed that in two non-hematological malignancies, ovarian carcinoma22 and mesothelioma23, CD157 overexpression correlated with tumor invasiveness, aggressiveness, and decreased sensitivity to platinum-based chemotherapy24, suggesting that CD157 is more than a bystander marker.